Medicine and Dentistry
Bezafibrate
100%
Primary Biliary Cirrhosis
90%
Ursodeoxycholic Acid
72%
Combination Therapy
54%
Monotherapy
36%
Patient
36%
Therapeutic Procedure
27%
Hazard Ratio
18%
Liver Graft
18%
Analysis
18%
Liver
18%
Inpatient
18%
Serum
9%
Regression Analysis
9%
Proportional Hazards Model
9%
Bilirubin
9%
Liver Transplantation
9%
Survival
9%
Pharmacology, Toxicology and Pharmaceutical Science
Bezafibrate
100%
Primary Biliary Cirrhosis
90%
Ursodeoxycholic Acid
72%
Combination Therapy
54%
Monotherapy
36%
Death
18%
Prognosis
9%
Bilirubin
9%
Survival
9%
Biochemistry, Genetics and Molecular Biology
Bezafibrate
100%
Ursodeoxycholic Acid
72%
Bilirubin Blood Level
9%
Survival
9%
Immunology and Microbiology
Liver
36%
Transplantation
18%
Survival
9%
Liver Transplantation
9%
Bilirubin Blood Level
9%